COVID-19: A Brief Overview of the Discovery Clinical Trial

COVID-19: A Brief Overview of the Discovery Clinical Trial

Jean Jacques Vanden Eynde

The outbreak of COVID-19 is leading to a tremendous search for curative treatments. The urgency of the situation favors a repurposing of active drugs but not only antivirals. This short communication focuses on four treatments recommended by WHO and included in the first clinical trial of the European Discovery project.

2020

chloroquine, COVID-19, hydroxychloroquine, Lopinavir/ritonavir, remdesivir, repurposing

DOI: 10.3390/ph13040065

Pharmaceuticals

MDPI AG

Pharmacy and materia medica

EN